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S1. Complete extraction and isolation procedures.
The herbs of V. luteola (dried weight 3.5 kg) were grounded and extracted with methanol (20 L) exhaustively under reflux (85 °C) for 8 hours, and the resulting liquid was concentrated in vacuo to give a dark brown syrup (640 g). The methanol extract was partitioned between chloroform and water to produce chloroform soluble layer (190 g) and water soluble layer (450 g), respectively.
The chloroform layer was subjected to a silica gel column eluted with a step gradient of n-hexane and acetone (100:1 to 1:1) to afford seven fractions (CF 1 ~ 7) as monitored by TLC.
CF 3 was further column chromatographed on silica gel with a mixture of n-hexane and ethyl acetate (step gradient from 50:1 to 1:1) to afford fourteen subfractions . CF 3-2 was purified by silica gel column chromatography (SiO2 CC) to yield nine minor fractions which eluted with a step gradient mixture of n-hexane and ethyl acetate (100:1 to 1:1). The minor fraction 3-2-6 was recrystallized from chloroform to give 18 (0.3 g). CF 3-3 was isolated by SiO2 CC with a step gradient mixture of n-hexane and acetone eluent (50:1) to afford eleven minor fractions . The CF 3-3-4 was purified by repeated SiO2 CC eluted with n-hexane and acetone (step gradient 50:1 to 1:1) to yield 16 (0.8 mg), 17 (1.1 mg), and 40
(1.8 mg). CF 3-3-7 was purified by SiO2 CC with a mixture of n-hexane and acetone (50:1) and further recrystallization of the resulting fractions afforded a mixture of 19 and 20 (2.5 mg), a mixture of 23 and 24 (2.2 mg), respectively. CF 3-5 was separated by SiO2 CC eluted by chloroform/methanol (100:1 to 1:1) to afford fourteen minor fractions (3-5-1 ~ 3-5-14) .
Compounds 6 (1.6 mg) and 7 (4.3 mg) were yielded from CF 3-5-7 by preparative thin layer chromatography (pTLC) purification which developed with a solvent mixture of n-hexane and ethyl acetate (50:1). CF 3-5-10 was isolated by pTLC eluted with a solvent mixture of chloroform and methanol (100:1) to give 37 (4.2 mg) and 69 (0.6 mg). CF 3-5-11 was further separated by repeated SiO2 CC eluted with a step gradient mixture of chloroform and methanol (50:1 to 1:1) to result in 8 (5.4 mg), 14 (1.2 mg), 55 (1.8 mg), and 63 (2.0 mg). Fraction 6 (CF 6) was further subjected on a silica gel column and eluted with a chloroform and methanol mixture (step gradient from 50:1 to 1:1) to produce thirteen subfractions (CF 6-1 ~ 6-13). A mixture of 21 and 22 (4.3 mg) was obtained from CF 6-7 by recrystallization of ethyl acetate.
CF 6-8 was purified by SiO2 CC with a mixture of benzene and ethyl acetate (30:1) to yield ten minor fractions . CF 6-8-6 was further isolated by pTLC with a solvent mixture of chloroform and acetone (10:1) to obtain 41 (1.0 mg). CF 7 was isolated on a SiO2
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CC eluted with chloroform and methanol (step gradient from 50:1 to 1:1) to give twelve subfractions . CF 7-3 was further purified by SiO2 CC eluted with a mixture of chloroform and methanol (100:1) to obtain eight minor fractions (7-3-1 ~ 7-3-8) . CF 7-3-5 was subjected to pTLC with a solvent mixture of chloroform and methanol (30:1) to afford 68 (2.3 mg). CF 7-4 was isolated with SiO2 CC eluted with a mixture of chloroform and ethyl acetate (20:1) to produce ten minor fractions (CF 7-4-1 ~ 7-4-10). CF 7-4-3 was further purified by pTLC with a solvent mixture of n-hexane and ethyl acetate (20:1) to give 25 (1.9 mg) and 64
(1.5 mg). CF 7-5 was subjected to SiO2 CC eluted with a mixture of chloroform and methanol (5.0 mg), respectively. WF 5-5 was purified by reversed-phase HPLC with a Gemini 5u C18 column (250 × 4.6 mm, 5μm) eluted with a MeOH-H2O mixture (20:80, 0.6 mL/min) to afford 52 (4.2 mg). WF 6 was subjected to Diaion HP-20 CC eluted with water and a step gradient of methanol (10:0 to 0:10) to afford six subfractions (WF 6-1 ~ 6-6). WF 6-2 was further purified by SiO2 CC with a mixture of chloroform and methanol (50:1) to produce five minor fractions (WF 6-2-1 ~ 6-2-5). WF 6-2-4 was separated by pTLC with a solvent mixture of chloroform, methanol and water (10:1:0.1) to obtain 5 (4.0 mg), 12 (2.6 mg) and 49 (3.3 mg) . WF 6-6 was resolved on SiO2 CC eluted with ethyl acetate and methanol (300:1) to give seven minor fractions (WF 6-6-1 ~ 6-6-7). WF 6-6-7 was isolated by pTLC eluted with chloroform and methanol (10:1) to yield 15 (3.5 mg) and 58 (0.4 g). WF 7 was purified by Diaion HP-20 CC eluted with water and a step gradient of methanol (10:0 to 0:10) to obtain seven subfractions (WF 7-1 ~ 7-7). WF 7-6 was separated by repeated Sephadex LH-20 CC eluted with a step gradient mixture of water and methanol (10:0 to 0:10) to yield 1 (2.8 mg), 9 (17.0 mg), 11 (5.2 mg), 47 (2.6 g), 59 (1.5 g), and 60 (0.5 g). WF 8 was purified by SiO2 CC eluted by chloroform and a step gradient with methanol and water (100:1:0.1 to 1:1:0.1) to obtain seven subfractions . WF 8-4 was isolated by SiO2 CC with a solvent mixture of ethyl acetate and methanol (20:1) to give five minor fractions . WF 8-4-3 was recrystallized with ethyl acetate to give 45 (2.7 mg). WF 8-4-5 was resolved on pTLC and purified with a solvent mixture of chloroform, methanol and water (6:1:0.1) to yield 13 (1.1 mg) and 72 (1.9 mg). Fraction 10 (WF 10) was subjected to Sephadex LH-20 CC eluted with water and a step gradient of methanol (10:0 to 0:10) to obtain ten subfractions (WF 10-1 ~ 10-10). WF 10-3 was purified by pTLC with a solvent mixture of chloroform and ethyl acetate (3:1) to give 42 (0.8 mg). WF 10-6 was isolated by SiO2 CC eluted with ethyl acetate, methanol and water (50:1:0.1) to produce seven minor fractions (WF 10-6-1 ~ 10-6-7). WF 10-6-6 was purified by repeated
SiO2 CC eluted with a mixture of ethyl acetate and methanol (step gradient from 50:1 to 5:1) to yield 31 (4.2 mg), 46 (12.3 mg), and 50 (11.0 mg). WF 10-9 was separated by repeated SiO2 to result in 3 (6.3 mg), 27 (33.0 mg), and 28 (43.3 mg). WF 14 was subjected to SiO2 CC eluted with ethyl acetate and methanol (step gradient from 300:1 to 1:1) to give nine subfractions (WF 14-1 ~ 14-9). Compound 29 (7.5 mg) was obtained from the WF 14-7 by repeated SiO2 CC eluted with a solvent mixture of chloroform and methanol (50:1) followed by recrystallization.
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S2. References of the known compounds.
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